0001209191-23-007770.txt : 20230208 0001209191-23-007770.hdr.sgml : 20230208 20230208160526 ACCESSION NUMBER: 0001209191-23-007770 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230206 FILED AS OF DATE: 20230208 DATE AS OF CHANGE: 20230208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Young Joseph R CENTRAL INDEX KEY: 0001861684 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40407 FILM NUMBER: 23599065 MAIL ADDRESS: STREET 1: C/O VERA THERAPEUTICS, INC. STREET 2: 8000 MARINA BOULEVARD, SUITE 120 CITY: BRISBANE STATE: CA ZIP: 94005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vera Therapeutics, Inc. CENTRAL INDEX KEY: 0001831828 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 812744449 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8000 MARINA BOULEVARD, SUITE 120 CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 650-770-0077 MAIL ADDRESS: STREET 1: 8000 MARINA BOULEVARD, SUITE 120 CITY: BRISBANE STATE: CA ZIP: 94005 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-06 0 0001831828 Vera Therapeutics, Inc. VERA 0001861684 Young Joseph R C/O VERA THERAPEUTICS, INC. 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005 0 1 0 0 SVP, Finance, Chief Acct Offcr Class A Common Stock 2022-02-06 4 P 0 5714 7.00 A 22679 D Shares purchased by the Reporting Person in the Issuer's follow-on offering, which closed on February 6, 2023. The purchase price is the offering price. Includes 817 shares acquired under the Issuer's Employee Stock Purchase Plan on September 13, 2022. /s/ Joseph R. Young 2023-02-08